Evidence map›Paper›PMID 25984907›Full record

ArticleScientific reports2015

Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma.

Devyani Samantarrai, Mousumi Sahu, Jyoti Roy, Bedanta Ballav Mohanty, Garima Singh, Chandra Bhushan, Bibekanand Mallick

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Devyani SamantarraiRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
Mousumi SahuRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
Jyoti RoyRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
Bedanta Ballav MohantyRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
Garima SinghRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
Chandra BhushanRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
Bibekanand MallickRNAi and Functional Genomics Laboratory, Department of Life Science, National Institute of Technology, Rourkela, India.
National Institute of Technology Rourkela · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer metastasis is a disease of extreme clinical relevance, as it is responsible for more than 90% of cancer-associated mortality. The molecular mechanism and critical regulators involved in this complex multi-stage process of metastasis is poorly deciphered in soft tissue sarcomas (STS), a heterogeneous group of rare tumors with high metastatic potential. Therefore, we aimed at identifying miRNA and transcription factor (TF) regulatory networks and paths in STS metastasis. We integrated mRNA and miRNA expression profiles with curated regulations (TF→gene, TF→miRNA, miRNA→gene) from different databases and constructed a potentially active regulatory sub-network in STS metastasis. From functional and topological analysis, we found nine novel regulators of Notch signaling sub-network which are conjectured to play critical role in metastasis of STS. This illustrated that the sub-network is promising for identification of critical regulators. Further analysis deploying our developed tool 'RiNAcyc' and computing coverage ratio of known STS associated genes and miRNAs identified a 15 node active path. This potential path highlights the crucial role of BMP2, hsa-miR-24, AP2 and MYC as the up-stream regulators of the path and hsa-miR-215 and TYMS as potential indicator of chemotherapeutic benefit in STS metastasis.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMicroRNAsNeoplasm MetastasisRNA InterferenceRNA, MessengerSarcomaSignal TransductionTranscription FactorsMicroRNAsRNA, MessengerTranscription Factors

Identifiers

PMID25984907
PMCPMC4434893
OpenAlexW988619879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.